HealthStream: Q2 Earnings Snapshot

HealthStream Inc. (HSTM) reported Q2 profit of $6.7 million, or 23 cents per share, on revenue of $83.7 million. The company expects full-year revenue of $327 million to $332 million, according to the report.

Original reporting
Published Aug 3, 2026, 10:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 3, 2026, 11:04 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$HSTM
Neutral
medium confidence
Mentioned
$HSTM
Relevance
7/10
alphai data visualization · based on greenevillesun.com
Decision brief

The 30-second read

$HSTMNeutralMed
01

Why it matters

The key tradable elements are the reported Q2 profit and revenue, and the stated full-year revenue outlook ($327M to $332M), which can shift analyst models and near-term expectations.

02

Market read

This is a straightforward earnings snapshot with explicit full-year revenue guidance, which can affect estimates and short-term positioning.

03

What to watch

Traders may focus on margins, backlog, and customer retention, none of which are detailed in this snapshot, so the earnings headline may not capture the true driver.

Relevance 7/10Novelty 7/10Timing: reported Monday after-hours/late-day (published 2026-08-03 22:45 UTC)

Background

HealthStream is an internet-based provider of educational and training content for healthcare professionals.

Company-level read

Ticker impact

$HSTMNeutralMedium confidence
Context

HealthStream reported Q2 profit of $6.7M (23 cents/share) and revenue of $83.7M, plus full-year revenue guidance of $327M to $332M.

Expected impact

Likely modest volatility around the earnings release and guidance range, with direction dependent on how the numbers compare to Street expectations.

Evidence & confidence

It includes both reported quarterly results and explicit full-year revenue guidance, but it does not provide consensus comparisons or a surprise magnitude.

Market effects

Adds incremental signal for health-care education and training software/content demand trends, but impact is company-specific.

Limited, as the disclosure is for a single US-listed issuer.

Low, no international or macro linkage beyond healthcare training spend.

Counterpoint

If the guidance range is broadly in line with expectations, the market reaction may fade quickly and the stock may trade more on forward bookings/renewals than on this revenue band.

Key entities

  • HealthStream Inc.

    Reported Q2 profit and revenue and issued full-year revenue guidance.

Related articles

$HMNMed

Horace Mann Educators Q2 Earnings Call Highlights

Horace Mann (NYSE:HMN) reported Q2 call highlights. Management said auto frequency and severity trends were favorable and liability losses mid-single digits. It cut its full-year catastrophe-loss assumption to about $75M from $90M, while lowering total net investment income outlook to $465M-$475M. Revenue rose 8% YoY; life sales +20%.

$MURMedAI 8/10

Murphy Oil Sees Sharp Profit Increase

Murphy Oil Corp reported Q2 2026 adjusted net income of $225.8 million, nearly six times Q2 2025, as higher oil prices offset lower production and weaker gas. Adjusted EPS was $1.55 vs $1.51 consensus. Revenue rose to $926.3 million. Murphy kept its $0.35 dividend and raised 2026 capex midpoint to $1.55 billion.

$GSBDMed

Goldman Sachs BDC Q2 Earnings Call Highlights

Goldman Sachs BDC (NYSE:GSBD) reported no incentive fee in Q2, citing its three-year total-return lookback provision. NAV was $12.06/share at June 30 vs $12.17 in Q1. The board declared a Q3 base dividend of $0.32/share plus $0.03 supplemental. Investments were $3.2B fair value, non-accrual 2.9%, and net debt-to-equity 1.35x.

$HBBMed

Hamilton Beach Brands Q2 Earnings Call Highlights

Hamilton Beach Brands (HBB) reported Q2 gross margin of 26.1% excluding tariff-related benefits, and said it expects 2026 revenue growth in the mid-single-digit range. Management forecast full-year gross margin to improve modestly and operating profit to decline by a high-single-digit percentage. Operating cash flow is expected at $35M to $45M. HBB ended with net cash of $51.5M.